Radiation Applications

Radioisotopes / Testing For Mo-99 Production To Begin At Darlington-2 Nuclear Power Plant In Canada

By David Dalton
5 July 2022

‘Essential’ radionuclide used to detect illnesses like cancer and heart disease
Testing For Mo-99 Production To Begin At Darlington-2 Nuclear Power Plant In Canada
The isotope irradiation system at the Darlington-2 nuclear plant in Canada. Courtesy Laurentis Energy Partners.
A system being installed at the Darlington nuclear power station in Canada that will allow the Unit 2 reactor to produce a much-needed medical radioisotope, or radionuclide, has reached the “energisation” milestone, enabling preliminary testing to begin.

Want to know more?
Sign up.

Pen Use this content

Tags


Related